Provided by Tiger Fintech (Singapore) Pte. Ltd.

WUXI BIO

23.550
+0.4501.95%
Volume:54.49M
Turnover:1.30B
Market Cap:96.72B
PE:26.89
High:24.250
Open:23.600
Low:23.400
Close:23.100
Loading ...

Stock Track | WuXi Biologics Plummets 5.66% as Company Sells Irish Vaccine Facility Ahead of Potential U.S. Restrictions

Stock Track
·
07 Jan

BUZZ-Hong Kong-listed WuXi Biologics falls as co sells Irish vaccine facility

Reuters
·
07 Jan

BRIEF-Candid Therapeutics Enters Into Agreement With Wuxi Biologics On Trispecific T-Cell Engager

Reuters
·
07 Jan

Candid Therapeutics Enters Into Agreement With WuXi Biologics on Trispecific T-Cell Engager

THOMSON REUTERS
·
07 Jan

Candid - Plans to Complete Ind Enabling Studies to Enable First-in-Human Studies in First Half of 2026

THOMSON REUTERS
·
07 Jan

Candid Therapeutics - WuXi Biologics to Receive up to $925 Million in Payments and Milestones

THOMSON REUTERS
·
07 Jan

Deals of the day-Mergers and acquisitions

Reuters
·
06 Jan

China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 million

Reuters
·
06 Jan

WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million

Reuters
·
06 Jan

BRIEF-Wuxi Biologics To Sell Assets Related To Vaccines Ireland Facility

Reuters
·
06 Jan

WuXi Biologics - Asset Transaction Related to Vaccines Ireland Facility

THOMSON REUTERS
·
06 Jan

WuXi Biologics - Total Consideration of Approximately US$500 Mln

THOMSON REUTERS
·
06 Jan

WuXi Biologics - Co and Wuxi Vaccines Ireland Entered Into Agreement With Msd International

THOMSON REUTERS
·
06 Jan

WuXi Biologics (Cayman) Inc.'s (HKG:2269) largest shareholders are individual investors with 50% ownership, institutions own 35%

Simply Wall St.
·
04 Jan

Hong Kong Stocks Close Down; SMIC Surges 6%; XPeng Falls 6%

Market Watcher
·
30 Dec 2024

Greater China Stocks Close Mixed; Shanghai Leads Gainers

Dow Jones
·
30 Dec 2024